Dutch bleeding study reveals Real-World use of reversal agent
NCT ID NCT05898412
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 31 times
Summary
This study reviewed medical records of 217 Dutch adults hospitalized with severe bleeding while taking a factor Xa inhibitor blood thinner. All patients received andexanet alfa to reverse the bleeding. Researchers wanted to understand patient characteristics and outcomes, including any blood clots that occurred within 30 days. The study did not test a new treatment but gathered real-world data to help doctors use this reversal drug more effectively.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMORRHAGE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Amsterdam, Netherlands
Conditions
Explore the condition pages connected to this study.